Pharmaceutical Intermediates Anticonvulsants Rufinamide
Rufinamide, derived from triazole, serves as an anticonvulsant prescribed for managing seizure disorders such as Lennox-Gastuat syndrome, a type of childhood epilepsy. Clinical trials indicate its effectiveness in addressing partial seizures.
CAS: 106308-44-5
Formula: C10H8F2N4O
Molecular Weight: 238.19
Target: GRM5
click to sign in and save
1-(2,6-Difluorobenzyl)-1H-1,2,3-triazole-4-carbonitrile